Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause serious skin problems that need careful management.

VEGF helps hair grow and determines follicle size by increasing blood vessel growth.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Modern science supports the use of some Ayurvedic plants for health, as ancient practices suggested.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

EGFR inhibitors can cause yellowish skin eruptions.

A patch made from human lung fibroblast material helps heal skin wounds effectively, including diabetic ulcers.

Epigenetic changes are crucial for stem cell behavior in skin wound healing and their disruption may lead to cancer.

Saw palmetto extracts might help treat male hair loss and need more research.

The Wnt/β-catenin signaling pathway is important for skin wound healing and affects inflammation, cell growth, and other healing processes.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Drugs like PDEI may help hair disorders like AGA.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Communication between blood vessel and hair follicle cells decreases with age, affecting hair growth and blood vessel formation.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.